Evaluation of P16/K67 dual stained slides as a biomarker for cervical cancer.

Ended Purchase Order Awarded Last action

Contract number
75N91019P00563
Awardee
Awarding agency
Obligated
$240,000

Award facts

Opportunity
Contract value 100% obligated
$240,000.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
325413 In-Vitro Diagnostic Substance Manufacturing
PSC
Q301 Reference Laboratory Testing
Set-aside
No set-aside
Competition
Not Competed · 1 offer Only One Source
Pricing
Firm Fixed Price
Place of performance
Oro Valley, AZ 85755, USA

Award details come from SAM.gov/FPDS.

About this award

Written by GovTribe AI ·

The National Cancer Institute awarded a purchase order to Ventana Medical Systems, Inc. for $240,000 on August 7, 2019, for evaluation of P16/K67 dual stained slides as a biomarker for cervical cancer. Work is performed in Oro Valley, Arizona. The order is firm fixed price with an ultimate completion date of August 6, 2020. The requirement originated from a special notice posted May 6, 2019, with a May 20 proposal due date.

Quick answers

Who was awarded contract 75N91019P00563?

75N91019P00563 was awarded to Ventana Medical Systems, Inc. by National Cancer Institute (National Institutes of Health) on August 7, 2019.

How much is contract 75N91019P00563 worth?

The government has obligated $240,000 on 75N91019P00563.

Was contract 75N91019P00563 competed?

The extent of competition for 75N91019P00563 was not competed. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award
Try for free Login